Document is current
Any future updates will be listed below
-
Authors
Setu, Md Asif Khan https://orcid.org/0000-0003-4195-4217
Horstmann, Jens
Schmidt, Stefan
Stern, Michael E.
Steven, Philipp
-
Funding
Funding for this research was provided by:
EC | Horizon 2020 Framework Programme (765608)
Universitätsklinikum Köln
- License Information
-
More Information
Article History
Received: 7 October 2020
Accepted: 21 March 2021
First Online: 7 April 2021
Competing interests
: MAKS, JH has no conflict of interest. SS is an employee of Heidelberg Engineering GmbH. MES is the chief scientific officer of ImmunEyez LLC and a member of the scientific advisory board of Novaliq GmbH. PS has received financial support from Novaliq GmbH, Roche, Bausch&Lomb, Ursapharm. The Division of Dry-eye and Ocular GvHD received donations from Novaliq, Ursapharm, and Juergen‚ and Monika Ziehm.
